Rao Sudha has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Rao Sudha is identified in the SEC filing context as the Chief Scientific Officer of Kazia Therapeutics Ltd as of the most recent filing dated 2026-06-23. In this role, Sudha Rao is described as overseeing the company's scientific strategy and research and development portfolio. The SEC filings confirm her position but do not provide additional biographical details such as education, prior roles, or specific achievements. Based on the CSO role, typical responsibilities would include scientific leadership, portfolio management of development programs, and coordination with regulatory activities to advance Kazia’s research initiatives.
Role
Chief Scientific Officer
Notability
60/100
Board memberships
Kazia Therapeutics Ltd
Awards & honors
CSO role at Kazia Therapeutics Ltd (as of 2026-06-23)
Rao Sudha is identified in the SEC filing context as the Chief Scientific Officer of Kazia Therapeutics Ltd as of the most recent filing dated 2026-06-23. In this role, Sudha Rao is described as overseeing the company's scientific strategy and research and development portfolio. The SEC filings confirm her position but do not provide additional biographical details such as educ…
How many SEC Form 4 filings has Rao Sudha submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Rao Sudha's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
